Sentry Investments’s Zymeworks ZYME Stock Holding History

Sentry Investments’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-24,722	Closed	-$206K	–	179
2017 Q2	$206K	Buy	+24,722	New	+$277K	﹤0.01%	164

Other funds holding ZYME

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sentry Investments's ZYME Position: Q3 2017 in Review

Sentry Investments sold out of Zymeworks (ZYME) in Q3 2017, closing a stake of 24,722 shares — an estimated $206K sold.

Sentry Investments first reported a position in ZYME in Q2 2017 and held it in 1 quarter. The position peaked at $206K in Q2 2017. 12 funds tracked by Wall St. Rank hold ZYME as of Q3 2017.

Sentry Investments reported no remaining Zymeworks position as of Q3 2017 after selling out during the quarter.
Sentry Investments sold 24,722 Zymeworks shares in Q3 2017, an estimated $206K.
Sentry Investments first reported a position in Zymeworks in Q2 2017 and held it in 1 quarter.
Sentry Investments's Zymeworks position peaked at $206K in Q2 2017.
12 funds tracked by Wall St. Rank held Zymeworks as of Q3 2017.

Based on Sentry Investments's 13F filing for Q3 2017, filed 14 Nov 2017.